ASSOCIATION DE KYNURENINE ET DE CELLULES PRESENTATRICES D'ANTIGENE (CPA) EN TANT QU'AGENT THERAPEUTIQUE, ET METHODES D'UTILISATION DE CETTE DERNIERE DANS LA MODULATION IMMUNITAIRE
This invention provides combinations of kynurenine and antigen presenting cells (APC) for modulating immune tolerance, wherein the combinations may be used to modulate an autoimmune response, which may be of use in the treatment of Type 1 Diabetes (T1D) or alopecia areata (AA). Uses of kynurenine and antigen presenting cells (APC) as an immune modulator for the treatment of T1D or AA are also provided.